BlackRock’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-253,357
Closed -$204K 5266
2020
Q2
$204K Sell
253,357
-49,263
-16% -$41.6K ﹤0.01% 4368
2020
Q1
$210K Sell
302,620
-3,055
-1% -$3.74K ﹤0.01% 4223
2019
Q4
$483K Sell
305,675
-7,372
-2% -$20.6K ﹤0.01% 4167
2019
Q3
$1.24M Sell
313,047
-41,476
-12% -$241K ﹤0.01% 3900
2019
Q2
$2.57M Sell
354,523
-255,581
-42% -$1.74M ﹤0.01% 3693
2019
Q1
$4.03M Sell
610,104
-10,756
-2% -$70.9K ﹤0.01% 3484
2018
Q4
$4.45M Buy
620,860
+50,950
+9% +$567K ﹤0.01% 3430
2018
Q3
$10.9M Buy
569,910
+5,466
+1% +$195K ﹤0.01% 3200
2018
Q2
$31.9M Buy
564,444
+56,518
+11% +$2.87M ﹤0.01% 2611
2018
Q1
$21.5M Sell
507,926
-1,379
-0.3% -$59.2K ﹤0.01% 2730
2017
Q4
$27.2M Buy
509,305
+5,675
+1% +$300K ﹤0.01% 2620
2017
Q3
$22.5M Buy
503,630
+5,262
+1% +$240K ﹤0.01% 2745
2017
Q2
$24.2M Sell
498,368
-3,554
-0.7% -$209K ﹤0.01% 2679
2017
Q1
$36.3M Buy
501,922
+501,268
+76,646% +$33.2M ﹤0.01% 2415
2016
Q4
$37K Sell
654
-10,347
-94% -$948K ﹤0.01% 3067
2016
Q3
$1.41M Buy
11,001
+546
+5% +$69.9K ﹤0.01% 1349
2016
Q2
$1.3M Sell
10,455
-1,154
-10% -$133K ﹤0.01% 1331
2016
Q1
$970K Sell
11,609
-131
-1% -$10.8K ﹤0.01% 1367
2015
Q4
$1.16M Buy
11,740
+11,302
+2,580% +$1.21M ﹤0.01% 1260
2015
Q3
$54K Buy
438
+300
+217% +$40.7K ﹤0.01% 1885
2015
Q2
$21K Sell
138
-9
-6% -$1.49K ﹤0.01% 2391
2015
Q1
$25K Hold
147
﹤0.01% 2259
2014
Q4
$23K Hold
147
﹤0.01% 2309
2014
Q3
$16K Hold
147
﹤0.01% 2467
2014
Q2
$22K Sell
147
-14
-9% -$1.86K ﹤0.01% 2342
2014
Q1
$21K Hold
161
﹤0.01% 2355
2013
Q4
$28K Hold
161
﹤0.01% 2199
2013
Q3
$26K Hold
161
﹤0.01% 2140
2013
Q2
$21K Buy
+161
New +$22.7K ﹤0.01% 2287

Other funds holding ELGX

BlackRock's ELGX Position: Q3 2020 in Review

BlackRock sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 253,357 shares — an estimated $204K sold.

BlackRock first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $36.3M in Q1 2017. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • BlackRock reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • BlackRock sold 253,357 Endologix Inc shares in Q3 2020, an estimated $204K.
  • BlackRock first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
  • BlackRock's Endologix Inc position peaked at $36.3M in Q1 2017.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on BlackRock's 13F filing for Q3 2020, filed 6 Nov 2020.